1027 related articles for article (PubMed ID: 33422448)
1. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
Zaliznyak M; Jung EE; Bresee C; Garcia MM
J Sex Med; 2021 Feb; 18(2):410-422. PubMed ID: 33422448
[TBL] [Abstract][Full Text] [Related]
2. A Proposed Inventory to Assess Changes in Orgasm Function of Transgender Patients Following Gender Affirming Treatments: Pilot Study.
Zaliznyak M; Lauzon M; Stelmar J; Yuan N; Smith SM; Garcia MM
Sex Med; 2022 Jun; 10(3):100510. PubMed ID: 35472753
[TBL] [Abstract][Full Text] [Related]
3. Variability in Medicaid Coverage for Gender-affirming Surgeries Across U.S. States.
Wu CA; Ho I; Minasian A; Keuroghlian AS; O'Brien-Coon D; Ranganathan K
Ann Surg; 2024 Mar; 279(3):542-548. PubMed ID: 37395609
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
[TBL] [Abstract][Full Text] [Related]
5. Insurance Coverage of Facial Gender Affirmation Surgery: A Review of Medicaid and Commercial Insurance.
Gorbea E; Gidumal S; Kozato A; Pang JH; Safer JD; Rosenberg J
Otolaryngol Head Neck Surg; 2021 Dec; 165(6):791-797. PubMed ID: 33722109
[TBL] [Abstract][Full Text] [Related]
6. Barriers and Facilitators to Gender-affirming Hormone Therapy in the Veterans Health Administration.
Wolfe HL; Boyer TL; Shipherd JC; Kauth MR; Jasuja GK; Blosnich JR
Ann Behav Med; 2023 Nov; 57(12):1014-1023. PubMed ID: 37436725
[TBL] [Abstract][Full Text] [Related]
7. How Accessible Is Genital Gender-Affirming Surgery for Transgender Patients With Commercial and Public Health Insurance in the United States? Results of a Patient-Modeled Search for Services and a Survey of Providers.
Terris-Feldman A; Chen A; Poudrier G; Garcia M
Sex Med; 2020 Dec; 8(4):664-672. PubMed ID: 33023854
[TBL] [Abstract][Full Text] [Related]
8. New Insights Into Extended Steroid Hormone Profiles in Transwomen in a Multi-Center Setting in Germany.
Schneider F; Wistuba J; Holterhus PM; Kulle A; Schlatt S; Kliesch S; Neuhaus N; Zitzmann M
J Sex Med; 2021 Oct; 18(10):1807-1817. PubMed ID: 34600646
[TBL] [Abstract][Full Text] [Related]
9. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V
J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and Factors Associated With Gender-Affirming Surgery Among Transgender Women & Transgender Men in a Community-Based Clinic in Metro Manila, Philippines: A Retrospective Study.
Eustaquio PC; Castelo AV; Araña YS; Corciega JOL; Rosadiño JDT; Pagtakhan RG; Regencia ZJG; Baja ES
Sex Med; 2022 Apr; 10(2):100497. PubMed ID: 35247792
[TBL] [Abstract][Full Text] [Related]
11. Gender Affirming Medical Treatment Desire and Treatment Motives in Binary and Non-Binary Transgender Individuals.
Kennis M; Duecker F; T'Sjoen G; Sack AT; Dewitte M
J Sex Med; 2022 Jul; 19(7):1173-1184. PubMed ID: 35418328
[TBL] [Abstract][Full Text] [Related]
12. How Early in Life do Transgender Adults Begin to Experience Gender Dysphoria? Why This Matters for Patients, Providers, and for Our Healthcare System.
Zaliznyak M; Yuan N; Bresee C; Freedman A; Garcia MM
Sex Med; 2021 Dec; 9(6):100448. PubMed ID: 34731778
[TBL] [Abstract][Full Text] [Related]
13. The Informed Consent Model of Care for Accessing Gender-Affirming Hormone Therapy Is Associated With High Patient Satisfaction.
Spanos C; Grace JA; Leemaqz SY; Brownhill A; Cundill P; Locke P; Wong P; Zajac JD; Cheung AS
J Sex Med; 2021 Jan; 18(1):201-208. PubMed ID: 33249011
[TBL] [Abstract][Full Text] [Related]
14. Comprehensiveness of Online Information in Gender-Affirming Surgery: Current Trends and Future Directions in Academic Plastic Surgery.
Aryanpour Z; Nguyen CT; Blunck CK; Cooper KM; Kovac S; Ananthasekar S; Peters BR
J Sex Med; 2022 May; 19(5):846-851. PubMed ID: 35288048
[TBL] [Abstract][Full Text] [Related]
15. The Desire and Status of Gender-Affirming Hormone Therapy and Surgery in Transgender Men and Women in China: A National Population Study.
Liu Y; Xin Y; Qi J; Wang H; Hong T; Yang X; Li B; Chang X; Knudson G; Zhao Z; Pan B
J Sex Med; 2020 Nov; 17(11):2291-2298. PubMed ID: 32868262
[TBL] [Abstract][Full Text] [Related]
16. Associations Between Transgender Exclusion Prohibitions and Insurance Coverage of Gender-Affirming Surgery.
Almazan AN; Benson TA; Boskey ER; Ganor O
LGBT Health; 2020 Jul; 7(5):254-263. PubMed ID: 32380882
[No Abstract] [Full Text] [Related]
17. Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI).
Cocchetti C; Castellini G; Iacuaniello D; Romani A; Maggi M; Vignozzi L; Schreiner T; den Heijer M; T'Sjoen G; Fisher AD
J Sex Med; 2021 Apr; 18(4):821-829. PubMed ID: 33745831
[TBL] [Abstract][Full Text] [Related]
18. A National Survey of United States-Based Endocrinologists Who Prescribe Gender-Affirming Hormone Therapy.
Bisno DI; Lubitz S; Marshall I; Cohen DA
Endocr Pract; 2023 Jun; 29(6):465-470. PubMed ID: 36906069
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
